GlassScriptPhysician profile
Stanley H Feil
NPI 1942205240
$6,593.90
in general payments reported to CMS, 2019-2025
29 companies · $831 in 2025
The $831 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,487 · 2020: $451 · 2021: $711 · 2022: $963 · 2023: $1,090 · 2024: $1,061 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,982.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,276.57 | 2019-2025 | Kxl System (Not Refurbished), Ce-Marked Kxla System, Photrexa Cross-Linking Kit |
| Alcon Vision LLC | $708.83 | 2019-2025 | Clareon, Rocklatan, Acrysof Iq Panoptix Uv Iol |
| Aerie Pharmaceuticals, INC. | $576.56 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $505.97 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $407.96 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $369.73 | 2019-2023 | |
| Sight Sciences, INC. | $345.49 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $335.70 | 2019-2024 | Tecnis Simplicity, Tecnis Iol, Whitestar Signature Pro |
| Kala Pharmaceuticals, INC. | $335.06 | 2019-2022 | |
| Dompe US, INC. | $207.53 | 2019-2025 | Oxervate |
| Amgen INC. | $165.58 | 2024-2025 | Tepezza |
| Apellis Pharmaceuticals, INC. | $164.99 | 2023-2025 | Syfovre |
| Rxsight INC | $157.60 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $152.76 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $144.04 | 2021-2025 | Acthar |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $125.62 | 2021-2022 | |
| Abbvie INC. | $106.04 | 2023-2025 | |
| Omeros Corporation | $68.59 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $65.52 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $58.95 | 2022-2023 | Tepezza |
| Ivantis, INC | $56.97 | 2019 | |
| Rayner Intraocular Lenses Limited | $46.95 | 2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Oyster Point Pharma, INC. | $45.47 | 2024-2025 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $45.23 | 2019-2020 | |
| Thea Pharma INC. | $32.14 | 2023-2025 | Iyuzeh |
| Astellas Pharma US INC | $25.86 | 2025 | Izervay |
| Carl Zeiss Meditec USA, INC. | $21.21 | 2022 | |
| Genentech USA, INC. | $20.62 | 2022 | |
| Carl Zeiss Meditec, INC. | $20.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Feil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.